Skip to main content
. Author manuscript; available in PMC: 2016 Apr 11.
Published in final edited form as: Mol Carcinog. 2012 Dec 19;53(5):403–412. doi: 10.1002/mc.21988

Figure 7.

Figure 7

Shikonin blocked TPA-induced inactivation of AMPK. (A) Western blot analysis to detect AMPK. Cells were treated with TPA (100 nM) or shikonin (1 μM) for 4 h. (B) Quantification of the protein levels of p-AMPK. The level of p-AMPK was normalized to that of β-actin. *P < 0.05 compared with the control (DMSO) treatment; #P < 0.05 compared with the TPA treatment.